Method for producing three-dimensional cell structure

By culturing cells in a configured chamber to form a three-dimensional structure exceeding its boundaries, the method addresses the suturing weakness of conventional cell structures, enabling stronger, transplantable artificial skin.

JP2024158963AActive Publication Date: 2024-11-08KYOTO UNIV +2
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2023074637
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-04-28
Publication Date
2024-11-08
Estimated Expiration
2043-04-28

Smart Images

  • Figure 2024158963000004
    Figure 2024158963000004
  • Figure 2024158963000005
    Figure 2024158963000005
  • Figure 2024158963000006
    Figure 2024158963000006
Patent Text Reader

Abstract

To provide a three-dimensional cell structure having strength that enables suturing.SOLUTION: This method for producing a three-dimensional cell structure includes: (1) a step for preparing original cells having proliferation capability, and a culture chamber which includes a cavity having an internal space surrounded by a lower surface, an upper surface, and side surfaces, and which is formed such that the culture liquid can circulate in the internal space; (2) a step for supplying the original cells to the culture chamber; (3) a step for holding the whole culture chamber in a culture liquid; and (4) a step for culturing the original cells, integrating the original cells, the cultured cells derived therefrom, and an extracellular matrix produced during the culturing, and forming a three-dimensional cell structure that has grown to the outside of the cavity.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for producing a three-dimensional cell structure, in particular a method for producing a three-dimensional cell structure with high strength and a three-dimensional cell structure produced by said method, as well as a method for producing artificial skin using the same and an artificial skin produced by said method. [Background technology]

[0002] In recent years, regenerative medicine using cultured cells has been attracting attention as a new medical technology. Research has been conducted on the creation of three-dimensional cell structures such as artificial tissues and artificial organs for the purpose of transplantation into the human body. Artificial skin is relatively easy to access because it is applied to the surface of the human body, and the condition after transplantation can be visually confirmed, and if there is a defective part, reoperation can be performed only on that part, making it an easy field to enter into in the field of regenerative medicine. In addition, three-dimensional cell structures such as artificial tissues and artificial organs can also be used for pharmacological or toxicity tests, or embryological tests. If three-dimensional cell structures can be created using human cells and tests can be easily performed in an environment similar to the in vivo environment, it is expected that drug discovery research, personalized drug diagnosis, or observational studies of organ development can be carried out efficiently.

[0003] Patent Document 1 and Non-Patent Document 1 describe a method for producing a three-dimensional cell structure by culturing and fusing a plurality of cell aggregates (spheroids) in a space within a support formed by a plurality of thread-like or needle-like members. In addition, as products in the field of artificial skin for clinical use, a cell sheet derived from human (autologous) epidermis and a bilayer artificial skin consisting of a collagen sponge layer and a reinforcing film have been approved. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] International Publication No. 2018 / 051415 [Non-patent literature]

[0005] [Non-Patent Document 1] Bioengineering of a scaffold-less three-dimensional tissue using net mold, Katsuhisa Sakaguchi et al 2021 Biofabrication 13 045019, https: / / doi.org / 10.1088 / 1758-5090 / ac23e3 Summary of the Invention [Problem to be solved by the invention]

[0006] Three-dimensional cell structures produced by conventional methods and epidermis-derived cell sheets and artificial skin used in clinical practice do not have the strength required for suturing, and therefore their range of use is limited. Therefore, an object of the present invention is to provide a three-dimensional cell structure having the strength required for suturing. [Means for solving the problem]

[0007] As a result of intensive research aimed at solving the above problems, the present inventors discovered that a three-dimensional cell structure having sufficient strength for suturing can be produced by three-dimensionally culturing original cells containing fibroblasts and / or cells capable of differentiating into fibroblasts using a specific method, and thus completed the present invention. That is, the present invention provides a method for producing a three-dimensional cell structure, a method for producing an artificial skin, a three-dimensional cell structure, and an artificial skin, as shown below. [1] A method for producing a three-dimensional cell structure, comprising the steps of: (1) preparing a culture chamber including a cavity having an internal space surrounded by a lower surface, an upper surface, and a side surface, and configured so that a culture medium can circulate within the internal space; (2) supplying the source cells to the culture chamber; (3) maintaining the entire culture chamber in a culture solution; (4) culturing the original cells to form a three-dimensional cell structure that is composed of the original cells, cultured cells derived therefrom, and an extracellular matrix produced during the culture, and that has grown to the outside of the cavity; A method comprising: [2] The method according to [1], wherein the original cells include fibroblasts and / or cells having the ability to differentiate into fibroblasts. [3] The method according to [1], wherein the original cells are in the form of spheroids. [4] The method described in [1], wherein step 2 includes a step of filling the internal space of the cavity with the original cells. [5] The method described in [1], wherein the original cells are cultured until the breaking strength of the three-dimensional cell structure is 0.08 N or more. [6] The method according to [1], further comprising a step of recovering the portion of the three-dimensional cell structure that has overflowed outside the cavity. [7] The method according to [1], wherein the three-dimensional cell structure comprises cultured dermis. [8] The method according to [1], wherein the lower surface and / or the upper surface of the cavity is comb-shaped or mesh-shaped. [9] The method according to [1], wherein the side of the cavity is formed by stacking multiple frames.

[10] A method for producing artificial skin, comprising a step of laminating the three-dimensional cell structure produced by the method according to any one of [1] to [9] above, on an epidermis member.

[11] A three-dimensional cell structure containing original cells used at the start of culture, the original cells being integrated with cultured cells derived therefrom and an extracellular matrix produced during culture, A three-dimensional cellular structure having a breaking strength of 0.08N or more.

[12] The three-dimensional cell structure described in

[11] , wherein the original cells include fibroblasts and / or cells having the ability to differentiate into fibroblasts.

[13] The three-dimensional cell structure described in

[11] above, which comprises cultured dermis.

[14] An artificial skin comprising the three-dimensional cell structure according to any one of

[11] to

[13] above and an epidermis member laminated thereon. Effect of the Invention

[0008] According to the present invention, a three-dimensional cell structure having sufficient strength for suturing can be produced by growing the three-dimensional cell structure until it overflows from the cavity of the culture chamber, and therefore a three-dimensional cell structure useful for transplantation into a living body can be provided. [Brief description of the drawings]

[0009] [Figure 1] As one embodiment of the present invention, a schematic diagram is shown of a culture chamber cavity whose upper, lower, and side surfaces are formed by wire, and source cells are supplied into the cavity so that the entire culture chamber is maintained in culture medium. [Diagram 2] As one embodiment of the present invention, schematic diagrams are shown of (a) the internal space of the culture chamber cavity being filled with original cells, (b) a three-dimensional cell structure being formed within the cavity, and (c) the three-dimensional cell structure growing until it overflows from the cavity. [Figure 3A] 1 shows a stained photograph (HE staining) of a cross section of a three-dimensional cell structure produced as one embodiment of the present invention. [Figure 3B] 1 shows a stained photograph (EVG staining) of a cross section of a three-dimensional cell structure produced as one embodiment of the present invention. [Figure 3C] 1 shows a stained photograph (stained with Alcian blue) of a cross section of a three-dimensional cell structure produced as one embodiment of the present invention. [Figure 3D] 1 shows a stained photograph (stained with anti-type I collagen antibody) of a cross section of a three-dimensional cell structure produced as one embodiment of the present invention. [Figure 3E] 1 shows a stained photograph (stained with anti-type II collagen antibody) of a cross section of a three-dimensional cell structure produced as one embodiment of the present invention. [Figure 4] Photographs showing the appearance of wound sites in transplantation experiments are shown. [Diagram 5]This shows a stained photograph (HE staining) of a section of the wound site in a transplantation experiment. The area enclosed by the dashed line is the transplanted three-dimensional cell structure (cultured dermis). [Figure 6] (a) shows a photograph of the appearance of original cells in the form of spheroids that were too large to fit into the cavity of the culture chamber when they were supplied to the culture chamber, and (b) shows a photograph of the appearance of the three-dimensional cell structure that was then formed after one month of culture. [Figure 7] A stained photograph (HE stained) of a cross section of a three-dimensional cell structure produced as one embodiment of the present invention, taken along line VV in FIG. 6b, and a partially enlarged photograph thereof are shown. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] The present invention will now be described in further detail. The present invention relates to a method for producing a three-dimensional cell structure, which includes a step (step 1) of preparing original cells having proliferation capacity and a culture chamber including a cavity having an internal space surrounded by a lower surface, an upper surface, and a side surface, and configured so that a culture medium can circulate within the internal space. The "three-dimensional cell structure" described in this specification refers to a three-dimensional structure formed by stacking multiple layers of cells, and refers to a cultured tissue that also contains an extracellular matrix.

[0011] The term "original cells" as used herein refers to cells to be cultured and used to start culturing. The original cells are not particularly limited as long as they can grow in vitro, and may include, for example, fibroblasts and / or cells capable of differentiating into fibroblasts, or embryonic stem cells or induced pluripotent stem cells. The original cells may be prepared as individual separated cells, or in the form of spheroids in which cells are aggregated together. The size of the spheroids is not particularly limited, and may be, for example, about 100 to about 300 μm, about 100 to about 500 μm, about 100 to about 750 μm, about 100 to about 1000 μm, or about 100 to about 2500 μm in particle size.

[0012] In the culture chamber, since the culture fluid needs to be able to circulate in the internal space of the cavity, the lower surface, upper surface, or side surface of the culture chamber and the cavity has a gap through which the culture fluid can pass. The method of forming the gap is not particularly limited, but for example, the lower surface and / or upper surface of the cavity may be comb-shaped or mesh-shaped, and the side surface of the cavity may be formed by stacking a plurality of frames, and a gap may exist between the frames. Specifically, as shown in FIG. 1, the lower surface, upper surface, and side surface of the cavity of the culture chamber may be composed of a plurality of wires 1 arranged in a comb shape. The culture fluid can freely pass through the gap between the wires and circulate in the internal space 11 of the cavity of the culture chamber. More specifically, the culture chamber described in Patent Document 1 or Non-Patent Document 1 or a commercially available net mold (manufactured by Tissue By Net Co., Ltd.) may be used.

[0013] The method of the present invention includes a step of supplying the original cells to the culture chamber (step 2). In this step, the original cells may be supplied into the internal space of the cavity of the culture chamber, or may be placed at the top of the cavity and then pushed into the internal space of the cavity when the top surface of the culture chamber is set.

[0014] In one embodiment, step 2 includes filling the internal space of the cavity with the original cells. Here, "filling" refers to a state in which the original cells are introduced into the cavity until they come into contact with the upper surface of the cavity, and also includes a state in which the original cells are introduced into the cavity until they come into contact with the upper surface of the cavity as a result of placing the original cells in the upper part of the cavity and pushing them in when setting the upper surface of the culture chamber.

[0015] The method of the present invention includes a step (step 3) of holding the entire culture chamber in culture fluid. In the culture chamber, the culture fluid can circulate within the internal space of the cavity. For example, as shown in FIG. 1, if original cells 2 are supplied to the internal space 11 of the cavity of the culture chamber and then the entire culture chamber is held in culture fluid 3, the culture fluid will be distributed to the original cells supplied to the internal space of the cavity. The composition of the culture fluid is not particularly limited and can be selected appropriately depending on the type of original cells and the purpose of culture.

[0016] The method of the present invention includes a step (step 4) of culturing the original cells to form a three-dimensional cell structure that is composed of the original cells, the cultured cells derived therefrom, and the extracellular matrix produced during the culture, and that has grown to the outside of the cavity. That is, in the method of the present invention, the culture is continued until the three-dimensional cell structure formed exceeds any one of the upper surface, lower surface, and side surface of the cavity and overflows to the outside. For example, as shown in FIG. 2, the culture is started by filling the internal space of a cavity whose upper surface, lower surface, and side surface are composed of a plurality of wires 1 with original cells 2 (FIG. 2a), and even if a three-dimensional cell structure 4 is formed in the internal space of the cavity, the culture is continued (FIG. 2b), and the three-dimensional cell structure 41 is grown until it overflows from the cavity (FIG. 2c). The three-dimensional cell structure 41 that has grown to overflow from the cavity is roughly divided into three parts, namely, a central part 413 in the cavity containing a large amount of original cells 2, an outermost layer 411, and an intermediate layer 412 (FIG. 2c).

[0017] In one aspect, a portion of a three-dimensional cellular structure overflowing from the side of a cavity may be integrated with a portion of another three-dimensional cellular structure overflowing from the side of a nearby cavity to form a larger three-dimensional cellular structure.

[0018] In conventional culture methods, the objective is to form a three-dimensional cell structure, which is composed of the original cells, the cultured cells derived from them, and the extracellular matrix produced during culture, by supporting it in the internal space of the cavity, and it was not assumed that the three-dimensional cell structure would grow outside the cavity. However, surprisingly, it was found that by continuing the culture even after the three-dimensional cell structure was formed in the internal space of the cavity and growing the three-dimensional cell structure to the outside of the cavity, the breaking force (breaking strength) of the three-dimensional cell structure increased, and a three-dimensional cell structure that could withstand suturing was formed.

[0019] The culture period of the original cells until the three-dimensional cell structure is formed in step 4 is not particularly limited, but may be about 2 months or more, about 3 months or more, about 4 months or more, or about 5 months or more, or about 10 months or less, or about 9 months or less, from the start of culture in a state where the internal space of the cavity is filled with the original cells, when a three-dimensional cell structure is produced in a single cavity. Alternatively, when original cells in the form of spheroids larger than the internal space of the cavity in the culture chamber are arranged at equal intervals on the cavity, and the upper surface of the culture chamber is set to start culture in a state where the spheroids are pressed into the internal space of the cavity, the culture period may be, for example, about 2 weeks or more, about 1 month or more, or about 8 months or less, or about 7 months or less, depending on the proportion of spheroids (original cells) occupying the entire culture chamber. In one embodiment, the original cells may be cultured until the breaking strength of the three-dimensional cell structure becomes about 0.08 N or more, about 0.1 N or more, about 0.2 N or more, or about 0.3 N or more. The breaking strength of the three-dimensional cell structure can be measured using a known breaking strength measuring device such as EZ Test (Shimadzu Corporation) or a tensile tester.

[0020] The three-dimensional cell structure produced by the method of the present invention has a strength that allows it to be sutured, and therefore can be advantageously used for transplantation into a living body. The method of use is not particularly limited, and for example, the three-dimensional cell structure may be transplanted as a cultured dermis into a skin defect such as a wound site, or the three-dimensional cell structure may be transplanted into a defect in an internal organ. Without being bound by a particular theory, for example, since the three-dimensional cell structure resembles the cellular tissue structure of a living body, it is considered that the three-dimensional cell structure functions as a scaffold at the transplant site, and cells around the transplant site can enter inside the three-dimensional cell structure, thereby promoting the regeneration of skin or organs at the defect site. The three-dimensional cell structure can be horizontally divided into upper and lower parts around the central part containing the original cells, and in the three-dimensional cell structure divided into upper and lower parts, the middle layer part containing a large number of non-stratified cells can be brought into contact with the surface of the transplant destination, so that cells around the transplant site can easily enter, and the function as a scaffold can be expected to be more effective.

[0021] In one embodiment, the method of the present invention may further include a step of recovering the portion of the three-dimensional cell structure that has spilled out of the cavity. After recovering the portion, by continuing to culture the remaining portion including the central portion of the three-dimensional cell structure, the three-dimensional cell structure will grow again to the outside of the cavity, and the spilled portion can be recovered and reused.

[0022] The method of the present invention may further include any step as long as it does not impair the object of the present invention. For example, the method of the present invention may further include a step of removing the formed three-dimensional cell structure from the culture chamber, and may include a step of replacing the culture medium and / or a step of washing the cells being cultured during step 4.

[0023] In another aspect, the present invention also relates to a three-dimensional cell structure that contains therein original cells used at the start of culture and is constituted by integrating the original cells with cultured cells derived therefrom and an extracellular matrix produced during culture, and the breaking strength of the three-dimensional cell structure is about 0.08 N or more, about 0.1 N or more, about 0.2 N or more, or about 0.3 N or more. The three-dimensional cell structure of the present invention can be prepared according to the method for producing a three-dimensional cell structure described above as one aspect of the present invention.

[0024] In another aspect, the present invention also relates to a method for producing artificial skin, which includes a step of laminating the three-dimensional cell structure produced by the method of the present invention described above as one aspect of the present invention with an epidermis member. Alternatively, the present invention also relates to artificial skin, which includes the three-dimensional cell structure described above as one aspect of the present invention and an epidermis member laminated thereon. The artificial skin is useful for transplantation into wound sites, etc.

[0025] The epidermis member may be any member used in the art without any particular limitation, and may be, for example, an epidermal cell sheet, etc. By laminating the three-dimensional cell structure and the epidermis member, the engraftment efficiency of the artificial skin when transplanted into a living body is increased.

[0026] The present invention will be specifically described below with reference to examples, but the scope of the present invention is not limited to these examples. EXAMPLES

[0027] [Test Example 1] Preparation of three-dimensional cell structure (1)Cell culture Normal human dermal fibroblasts (NHDF; CC-2509, Lonza) were cultured in FKCM medium (Fukoku) supplemented with 10% fetal bovine serum (Gibco FBS, Thermo Fisher Scientific) and 1% penicillin-streptomycin (Sigma-Aldrich) for 3 days in an incubator (37°C, 5% CO2). The expanded cells were passaged, and cells cultured for 4 to 5 passages were used for subsequent tests.

[0028] (2) Preparation of spheroids Spheroids were prepared on a silicon dimple plate (DP10-1, Tissue by Net). Specifically, NHDFs were collected using TrypLE Express (Thermo Fisher Scientific) and diluted to 1 × 10 in FKCM medium. 6 A cell suspension of 200 cells / mL was prepared. 20 mL of the cell suspension was seeded onto a silicon dimple plate (DP10-1, Tissue By Net Co., Ltd.) with 4,500 dimples per plate, and cultured in an incubator (37°C, 5% CO2) for 12 hours. As a result, spheroids with a diameter of approximately 200 μm were obtained.

[0029] (3) Preparation of three-dimensional cell structures The upper and lower surfaces of the net mold NM14-2 (Tissue by Net Co., Ltd.) are arranged with 100 μm diameter stainless steel wires in parallel (comb-like) at 100 μm intervals, so that the spheroids cannot pass through. In this test, the net mold NM14-2 was used and 10 sheets of 0.1 mm thick side nets were stacked to form a culture chamber including a cavity with an internal space of 6 mm x 6 mm x 1 mm. The above spheroids were supplied into this internal space by a conventional method, and the culture chamber was placed in a 120 mL sterile container (Thermo Fisher Scientific Co., Ltd.) containing 40 mL of FKCM medium (containing 10% fetal bovine serum and 1% penicillin-streptomycin).

[0030] The sterilized container including the culture chamber was placed in a high humidity compatible shaker CS-LR (Taitec) in an incubator (37°C, 5% CO2) and shaken at 40 rpm to promote circulation of the medium. In this manner, the spheroids were cultured for 2 to 6 months, with half the medium replaced every week. After 2 months of culture, the three-dimensional cell structure formed spilled out by about 500 μm from the top and bottom of the cavity, and spilled out by several millimeters from the sides of the cavity, but even with further culture, the thickness of the spilled parts from the top and bottom did not change much.

[0031] After the culture, the three-dimensional cell structure in the net mold was removed by a conventional method and used for the following tests. Samples with a diameter of 3 mm were prepared by cutting them with a biopsy punch with a diameter of 3 mm (Kai Industries).

[0032] (4) Tissue staining The three-dimensional cell constructs (cultured for 6 months) cut into pieces with a diameter of 3 mm were fixed in formalin and embedded in paraffin in a standard manner, and 5 μm-thick sections were prepared at the center of the three-dimensional cell constructs. These sections were stained with hematoxylin and eosin (HE), Elastica van Gieson (EVG), or Alcian blue, or immunostained with anti-type I collagen antibody or anti-type II collagen antibody in a standard manner.

[0033] The optical microscope photograph of HE staining (Fig. 3A) showed that outside the central part where the spheroids were present at the start of the culture, an intermediate layer with a relatively low cell density but which constituted tissue through the extracellular matrix, and an outermost layer containing a dense multilayer structure on the surface of the three-dimensional cell structure, were formed. The optical microscope photograph of EVG staining (Fig. 3B) showed that a three-dimensional cell structure mainly composed of collagen fibers was formed. The optical microscope photograph of Alcian blue staining (Fig. 3C) showed that acidic mucopolysaccharides were abundantly present in the intermediate layer of the three-dimensional cell structure. Furthermore, the optical microscope photographs of immunostaining with anti-type I collagen antibody or anti-type II collagen antibody (Fig. 3D and Fig. 3E) showed that type I collagen and type II collagen were widely present throughout the three-dimensional cell structure, especially in the outermost layer.

[0034] From the results of these tissue staining, it was understood that the three-dimensional cell structure is composed of the original cells used at the start of the culture, the cultured cells derived from them, and extracellular matrix such as acidic mucopolysaccharides and collagen.Furthermore, since the three-dimensional cell structure has a structure similar to the cellular tissue structure of the living body (e.g., the dermis structure), it is expected to have good compatibility when transplanted into the living body.

[0035] [Test Example 2] Characterization of three-dimensional cell structures (1) Measurement of breaking strength The three-dimensional cell structure was cut into a 6 mm square, and a polypropylene suture (thread size 5-0) was passed through the center 2.5 mm from the bottom, and the ends of the thread were tied to make the thread 5 cm long. The upper 3 mm part was clamped in the upper clamp of a breaking force measuring device (EZ Test, Shimadzu Corporation), and the lower end of the knotted thread was clamped in the lower clamp, and pulled at a speed of 100 mm / min until the cultured dermis broke.

[0036] (2) Measurement of dry weight The 6 mm three-dimensional cell structure was dried for 3 days using a freeze dryer VD-250R (Taitec Corporation), and its dry weight was measured using an electronic balance.

[0037] (3) Measurement of collagen content The amount of collagen in the 3-mm diameter three-dimensional cell structure sample was measured using a collagen quantification assay kit (QuickZyme Biosciences). The kit was operated according to the instruction manual, and the absorbance of the reaction reagent at 570 nm was measured using a microplate reader to calculate the amount of collagen.

[0038] (4) Measurement of sulfated glycosaminoglycan content The amount of sulfated glycosaminoglycan (sGAG) in the 3 mm diameter three-dimensional cell structure sample was measured using the Blyscan glycosaminoglycan assay kit (Biocolor). The kit was operated according to the instruction manual, and the absorbance of the reaction reagent at 656 nm was measured using a microplate reader to calculate the amount of sGAG.

[0039] (5) Comparison of viable cell counts The number of live cells in a 3 mm diameter three-dimensional cell structure sample was measured using Cell Count Reagent SF (Nacalai Tesque), a viable cell count measurement reagent using WST-8. The absorbance at a test wavelength of 450 nm and a reference wavelength of 650 nm was measured using a microplate reader according to the instruction manual, and the difference between the absorbance values ​​was used as an index of the number of live cells to compare the survival status of the cells in the three-dimensional cell structure.

[0040] (6) Test results The breaking force, dry weight, collagen amount, and sGAG amount measured using cultured dermis prepared by culturing for 2 months, 4 months, or 6 months are shown in Table 1. [Table 1]

[0041] Conventionally, the period for culturing spheroids using a net mold was about three weeks, but when the spheroids were cultured for longer than that, especially from about two months onwards, the breaking strength of the three-dimensional cell structure increased significantly. On the other hand, there was no significant difference in the dry weight of each three-dimensional cell structure, and the cell viability was maintained well despite the long-term culture. The amount of collagen and sGAG tended to decrease with the culture period.

[0042] For comparison, a commercially available artificial skin consisting of a collagen sponge layer (Pelnac G Plus (R) The breaking strength of the 3D cell structure (Gunze Co., Ltd.) was measured and found to be approximately 70 mN. The breaking strength of the 3D cell structure cultured for more than two months was higher, suggesting that it could withstand suturing.

[0043] [Test Example 3] Transplantation experiment (1) Experimental design and surgical procedures A three-dimensional cell structure (cultured dermis) prepared by culturing for four months using the method described in Test Example 1 was cut out with a 6 mm diameter biopsy punch (Kai Industries), and divided horizontally into two three-dimensional cell structures, one above the other, using forceps, and used in animal experiments. 24 BALB / cAJcl-nu / nu mice (male, 7 weeks old) (CLEA Japan) were bred in the usual manner and divided into three groups: a control group, a cultured dermis group, and a commercially available artificial dermis group. All painful procedures were performed under isoflurane anesthesia.

[0044] In the applied surgery, a doughnut-shaped silicone skin splint (outer diameter 18 mm, inner diameter 12 mm, thickness 0.5 mm; Fuji Systems Co., Ltd.) was attached to the skin with adhesive (Aron Alpha; Daiichi Sankyo Co., Ltd.). The skin splint was sewn to the skin with 5-0 nylon thread (Bear Medic Co., Ltd.) to prevent contraction of the wound site. Then, a full-thickness skin defect with a diameter of 6 mm was created in the center of the inside of the hole in the skin splint using a 6 mm diameter biopsy punch (Kai Industries Co., Ltd.) and scissors.

[0045] The skin defects of the cultured dermis and commercially available artificial dermis groups were treated with cultured dermis for transplantation or Pelnac G Plus.(R) (Gunze Co., Ltd.) was grafted onto each of the mice in the control group, and nothing was implanted into the skin defect of the mice in the control group. The wound site was covered with a silicone mesh sheet (diameter 6 mm, SI mesh, Alcare Co., Ltd.), which was then sewn to the epithelium at the edge with 5-0 nylon thread. To prevent contamination and mechanical stress, the wound site was further covered with gauze and fixed with surgical tape (Silkytex, Alcare Co., Ltd.). After the treatment, the mice were individually caged and kept in the animal facility.

[0046] (2) Assessment of wound healing Wound healing was evaluated on the 7th and 14th postoperative days. At each evaluation time point, four mice from each group were sacrificed by carbon dioxide inhalation, and macroscopic images of the wounds were taken with a digital camera. Samples of the wounds were collected along with the surrounding tissue, fixed in 10% formalin, embedded in paraffin, and sectioned axially through the center of each wound. The sections were then subjected to HE staining, azocarmine-aniline blue (AZAN) staining, and CD31 immunostaining.

[0047] The length of the neoepithelium was measured using an optical microscope on HE-stained sections. Because there were no hair follicles in the wound site or neoepithelium, but there were hair follicles in the surrounding tissue, the wound site was identified using the hair follicles as an indicator, and the layer of epithelial cells (stained dark blue with hematoxylin) formed in a line above the wound site was determined to be the neoepithelium.

[0048] The area of ​​newly formed dermis-like tissue above the muscle layer at the wound site was measured using a light microscope in AZAN-stained sections. The fibrous connective tissue in the granulation tissue was stained light blue with aniline blue and could be distinguished from the dermis at the wound edge, which was stained dark blue. The light blue-stained area was determined to be new dermis-like tissue, and its area was measured using BZ-X800 analysis software (Keyence Corporation).

[0049] The total area of ​​new capillaries per unit area of ​​new dermis-like tissue was measured in sections immunostained with anti-CD31 antibody (DAB staining) by a conventional method. A threshold was set for the brown color of DAB staining, and the area with a color density equal to or higher than this threshold was measured using BZ-X800 analysis software (Keyence Corporation). The area in which the tubular structure of blood vessels was visible was then measured, and the sum of the areas was calculated as the area of ​​new capillaries. The result was divided by the area of ​​the granulation area determined by AZAN staining to determine the area of ​​new capillaries per unit granulation area.

[0050] (3) Statistical analysis Statistical significance was assessed using the Tukey-Kramer multiple comparison test. All data are expressed as mean ± standard deviation, and P < 0.05 was considered statistically significant.

[0051] (4) Results Figure 4 shows photographs of the wound site immediately after surgery, on day 7 after surgery, and on day 14 after surgery. The wound was covered with a scab. No obvious signs of infection were observed, confirming that the procedure had been performed appropriately. Figure 5 shows a photograph of a section stained with HE from the wound site. The survival of the transplanted cultured dermis (area surrounded by a dashed line) was confirmed.

[0052] The length of the new epithelium at the wound site on days 7 and 14 after surgery is shown in Table 2. In the cultured dermis group, new epithelium was formed longer on days 7 and 14 after surgery compared to the control group and the commercially available artificial dermis group.

[0053] [Table 2]

[0054] When comparing the area of ​​neodermis-like tissue at the wound site on days 7 and 14 after surgery, there was no significant difference between the groups; however, in the cultured dermis group, there was a tendency for neodermis-like tissue to form over a larger area after day 7 after surgery compared to the control group and commercially available artificial dermis group.

[0055] The areas of new capillaries in the wound site on postoperative days 7 and 14 are shown in Table 3. In the cultured dermis group, more capillaries were formed on postoperative day 14 compared to the control group and artificial dermis group.

[0056] [Table 3]

[0057] (5) Discussion The three-dimensional cell structure produced according to the method of the present invention was engrafted on the wound site and functioned as cultured dermis. Fibroblasts are known to produce cytokines that promote angiogenesis, and therefore, when the three-dimensional cell structure was transplanted as cultured dermis, vascular epithelial cells and fibroblasts entered the interior, promoting the formation of new capillaries and new epithelial cells.

[0058] [Test Example 4] Co-culture with epidermal cell sheet The three-dimensional cell structure prepared by culturing for four months using the method described in Test Example 1 was cut out with a 6 mm diameter biopsy punch (Kai Industries), and divided horizontally into two three-dimensional cell structures, an upper one and an lower one, using tweezers to be used as cultured dermis for transplantation. A 24-well cell insert was set in a 24-well plate, and the cultured dermis for transplantation was placed in the cell insert with the part that had been the outermost layer of the three-dimensional cell structure facing up, and an epidermal cell sheet (Jace) cut out to the same size was placed on top of it. (R) Fibroblast serum-free medium (FKCM) containing 10% fetal bovine serum was added to each well at 0.9 mL each, and air-liquid interface culture was performed at 37°C in 5% CO2.

[0059] One day after co-culture, the co-culture was collected and transplanted to the skin defect in the same manner as in Test Example 3. When the wound healing state was checked on the 7th day after surgery, the engraftment of the transplanted co-culture and the formation of neoepithelium were confirmed.

[0060] [Test Example 5] Simplified culture of large three-dimensional cell structures NHDF in the form of spheroids were prepared in the same manner as in Test Example 1 (2), and large aggregates (diameter 1000 μm or more) were selected. A Net Mold NM14-2 (Tissue by Net Co., Ltd.) was prepared as a culture chamber, and the intervals between the stainless steel wires were adjusted to 1 mm both vertically and horizontally, and spheroids were placed at equal intervals on the cavity (a in FIG. 6). The top surface of the culture chamber was set in the usual manner, and the spheroids were pushed into the internal space of the cavity and cultured in the same manner as in Test Example 1 (3).

[0061] After culturing for one month, the upper and lower nets of the net mold were removed, leaving only the middle net, and a photograph of the appearance is shown in Fig. 6b. The original cells in the spheroid state spread over the entire culture chamber beyond the cavity part where they were placed at the beginning of the culture, and proliferated, forming a three-dimensional cell structure. When the cross section of this three-dimensional cell structure was stained, it was found that the cells had reached the edge of the three-dimensional cell structure, as shown in Fig. 7 (the large cavity in Fig. 7 is the trace of the wire that divided the cavity). In addition, looking at the enlarged photograph of a part in Fig. 7, it was confirmed that even in the three-dimensional cell structure produced by the method of this test example, outside the central part where the spheroids were present at the start of the culture, an intermediate layer with a relatively low cell density that constitutes tissue through the extracellular matrix, and an outermost layer containing a dense multi-layer structure on the surface of the three-dimensional cell structure were formed, that is, a structure similar to the cell tissue structure of a living body (for example, the dermis structure) was formed. Therefore, by adjusting the usage of the culture chamber, a three-dimensional cell structure of the desired size can be produced.

[0062] From the above, it was found that by growing the three-dimensional cell structure until it overflows from the cavity of the culture chamber, a three-dimensional cell structure strong enough to be sutured can be produced. Such a three-dimensional cell structure is useful as a biological transplant such as cultured dermis. [Explanation of symbols]

[0063] 1 Wire 11 Inner space of the culture chamber cavity 2 Original cell 3 Culture solution 4. Three-dimensional cell structure formed in the internal space of the cavity 41 Three-dimensional cell structure that has grown to overflowing from the cavity 411 Outermost layer of three-dimensional cell structure 412 Intermediate layer of three-dimensional cell structure 413 Central part of the 3D cell structure

Claims

1. A method for producing a three-dimensional cell structure, comprising the steps of: (1) preparing a culture chamber including a cavity having an internal space surrounded by a lower surface, an upper surface, and a side surface, and configured so that a culture medium can circulate within the internal space; (2) supplying the source cells to the culture chamber; (3) maintaining the entire culture chamber in a culture solution; (4) culturing the original cells to form a three-dimensional cell structure that is composed of the original cells, cultured cells derived therefrom, and an extracellular matrix produced during the culture, and that has grown to the outside of the cavity; A method comprising:

2. The method of claim 1 , wherein the source cells comprise fibroblasts and / or cells having fibroblast differentiation potential.

3. The method of claim 1 , wherein the source cells are in the form of spheroids.

4. The method of claim 1 , wherein step 2 comprises filling the interior space of the cavity with the ex-cells.

5. The method according to claim 1, wherein the original cells are cultured until the breaking strength of the three-dimensional cell structure is 0.08 N or more.

6. The method according to claim 1 , further comprising a step of recovering the portion of the three-dimensional cell structure that has overflowed outside the cavity.

7. The method according to claim 1 , wherein the three-dimensional cell structure comprises a cultured dermis.

8. The method according to claim 1 , wherein the lower and / or upper surface of the cavity is comb-shaped or mesh-shaped.

9. The method of claim 1 , wherein the sides of the cavity are formed by stacking a plurality of frames.

10. A method for producing artificial skin, comprising a step of laminating a three-dimensional cell structure produced by the method according to any one of claims 1 to 9 on an epidermis member.

11. A three-dimensional cell structure containing original cells used at the start of culture, the original cells being integrated with cultured cells derived therefrom and an extracellular matrix produced during culture, A three-dimensional cell structure having a breaking strength of 0.08 N or more.

12. The three-dimensional cell structure according to claim 11 , wherein the original cells include fibroblasts and / or cells having the ability to differentiate into fibroblasts.

13. The three-dimensional cell structure according to claim 11 , comprising cultured dermis.

14. An artificial skin comprising the three-dimensional cell structure according to any one of claims 11 to 13 and an epidermis member laminated thereon.

Citation Information

Patent Citations

  • Cell culture obtained using integrated three-dimensional cell printing technique, and method for preparing same

    EP3505614A1

  • Method for producing artificial skin model, and artificial skin model

    JP2012205516A

  • Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same

    JP2021045159A

  • Artificial skin having epithelial structure and method for producing the same

    JP2022032393A

  • High developed intelligence collaboration assistant system

    KR1020210116741A